Fujian Cosunter Pharmaceutical Hits Day High with 4.58% Surge

Fujian Cosunter Pharmaceutical Co., Ltd. has shown significant activity today, with the stock rising by 4.58% as of July 1, 2026. The stock reached an intraday high of CNY 113.33, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index only increased by 0.44% on the same day. Over the past week, Fujian Cosunter has demonstrated impressive growth, surging by 27.0%, while its one-month performance stands at 10.96%. The company has also outperformed the Shanghai Composite significantly over the past year, boasting a remarkable 207.23% increase compared to the index's 18.93%. Despite these gains, the company faces challenges, including operating losses and weak long-term fundamental strength. Key financial metrics indicate a net-debt-free status, but the return on equity is notably low at -96.35%. Additionally, the inventory turnover ratio is at its lowest, highlighting potential operational inefficiencies. As Fujian Cosunter navigates these complexities, its recent stock performance remains a focal point for market observers.